Gene · 780
Papers2,465
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 2,465
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deconvolution of multiplexed transcriptional responses to wood smoke particles defines rapid aryl hydrocarbon receptor signaling dynamics. | J Biol Chem | 2021 | 34520756 | PubTator, text mining | PubMed |
| In Vivo Efficacy of Imatinib Mesylate, a Tyrosine Kinase Inhibitor, in the Treatment of Chemically Induced Dry Eye in Animal Models. | Transl Vis Sci Technol | 2021 | 34520512 | PubTator, text mining | PubMed |
| Crowdsourced identification of multi-target kinase inhibitors for RET- and TAU- based disease: The Multi-Targeting Drug DREAM Challenge. | PLoS Comput Biol | 2021 | 34520464 | PubTator, text mining | PubMed |
| A Novel Scalarized Scaffold Hopping Algorithm with Graph-Based Variational Autoencoder for Discovery of JAK1 Inhibitors. | ACS Omega | 2021 | 34514265 | PubTator, text mining | PubMed |
| Periostin: An Emerging Molecule With a Potential Role in Spinal Degenerative Diseases. | Front Med (Lausanne) | 2021 | 34513869 | PubTator, text mining | PubMed |
| The Emerging Role of Non-coding RNAs in Drug Resistance of Ovarian Cancer. | Front Genet | 2021 | 34512721 | PubTator, text mining | PubMed |
| Development of a Selective Dual Discoidin Domain Receptor (DDR)/p38 Kinase Chemical Probe. | J Med Chem | 2021 | 34506142 | PubTator, text mining | PubMed |
| Merestinib monotherapy or in combination for japanese patients with advanced and/or metastatic cancer: A phase 1 study. | Cancer Med | 2021 | 34499416 | PubTator, text mining | PubMed |
| Molecular advances in pancreatic cancer: A genomic, proteomic and metabolomic approach. | World J Gastroenterol | 2021 | 34497442 | PubTator, text mining | PubMed |
| [Research Progress of Discoidin Domain Receptor 1 in Breast Cancer and Other Malignant Tumors]. | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | 2021 | 34494537 | PubTator, text mining | PubMed |
| Genomics and metabolomics of early-stage thioacetamide-induced liver injury: An interspecies study between guinea pig and rat. | Toxicol Appl Pharmacol | 2021 | 34492290 | PubTator, text mining | PubMed |
| Collagen- and hyaluronic acid-based hydrogels and their biomedical applications. | Mater Sci Eng R Rep | 2021 | 34483486 | PubTator, text mining | PubMed |
| New strategies for targeting kinase networks in cancer. | J Biol Chem | 2021 | 34461089 | PubTator, text mining | PubMed |
| Identification and Functional Validation of Differentially Expressed microRNAs in Ascites-Derived Ovarian Cancer Cells Compared with Primary Tumour Tissue. | Cancer Manag Res | 2021 | 34456588 | PubTator, text mining | PubMed |
| Use of Lipid-Modifying Agents for the Treatment of Glomerular Diseases. | J Pers Med | 2021 | 34442464 | PubTator, text mining | PubMed |
| Unraveling the IGF System Interactome in Sarcomas Exploits Novel Therapeutic Options. | Cells | 2021 | 34440844 | PubTator, text mining | PubMed |
| Myofibroblasts: Function, Formation, and Scope of Molecular Therapies for Skin Fibrosis. | Biomolecules | 2021 | 34439762 | PubTator, text mining | PubMed |
| Phosphoproteomics Identifies Significant Biomarkers Associated with the Proliferation and Metastasis of Prostate Cancer. | Toxins (Basel) | 2021 | 34437425 | PubTator, text mining | PubMed |
| Extracellular Matrix Protein Ratios in the Human Heart and Vessels: How to Distinguish Pathological From Physiological Changes? | Front Physiol | 2021 | 34421650 | PubTator, text mining | PubMed |
| Metformin Potentiates the Effects of Anlotinib in NSCLC via AMPK/mTOR and ROS-Mediated Signaling Pathways. | Front Pharmacol | 2021 | 34421608 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/780/papers?page=44